2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, Dassopoulos T, Bromfield GP, Dubois B, Cho JH, Brant SR, Duerr RH, Yang H, Rotter JI, Silverberg MS, Steinhart AH, Daly MJ, Podolsky DK, Louis E, Hafler DA, Rioux JD. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes & Immunity 2007, 8: 387-397. PMID: 17538633, DOI: 10.1038/sj.gene.6364398.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseCases of IBDRisk of IBDToll-like receptorsBowel diseaseIBD risk allelesUlcerative colitisCrohn's diseaseTLR4 pathwayIBD pathophysiologyIntestinal floraTLR pathwayTLR4 allelesHost defenseReceptor pathwayRisk allelesTLR genesDiseaseTLR4Modest effectHost/pathogen interactionsTIRAPAssociationReplication studyRisk
1987
Phosphorylation of CD4 and CD8 molecules following T cell triggering.
Blue ML, Hafler DA, Craig KA, Levine H, Schlossman SF. Phosphorylation of CD4 and CD8 molecules following T cell triggering. The Journal Of Immunology 1987, 139: 3949-54. PMID: 2961801, DOI: 10.4049/jimmunol.139.12.3949.Peer-Reviewed Original ResearchConceptsCell receptor complexCD3-T cell receptor complexT cell triggeringReceptor complexPhorbol myristate acetate (PMA) treatmentMolecular signaling mechanismsDifferent receptor pathwaysErythrocyte binding proteinCD8 moleculesSignaling mechanismBinding proteinPhosphorylationCell triggeringT cell activationCD2 pathwayT cellsReceptor pathwayMolecular modificationsT cell clonesCell activationCell clonesPathwayActivationCD4Cells